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Abstract
Background: Potential therapeutic use of mesenchymal stem cells (MSCs) is likely to require
large-scale in vitro expansion of the cells before transplantation. MSCs from adipose tissue can be
cultured extensively until senescence. However, little is known on the differentiation potential of
adipose stem cells (ASCs) upon extended culture and on associated epigenetic alterations. We
examined the adipogenic differentiation potential of clones of human ASCs in early passage culture
and upon senescence, and determined whether senescence was associated with changes in
adipogenic promoter DNA methylation.
Results: ASC clones cultured to senescence display reduced adipogenic differentiation capacity in
vitro, on the basis of limited lipogenesis and reduced transcriptional upregulation of FABP4 and LPL,
two adipogenic genes, while LEP and PPARG2 transcription remains unaffected. In undifferentiated
senescent cells, PPARG2 and LPL expression is unaltered, whereas LEP and FABP4 transcript levels
are increased but not in all clones. Bisulfite sequencing analysis of DNA methylation reveals overall
relative stability of LEP, PPARG2, FABP4 and LPL promoter CpG methylation during senescence and
upon differentiation. Mosaicism in methylation profiles is maintained between and within ASC
clones, and any CpG-specific methylation change detected does not necessarily relate to
differentiation potential. One exception to this contention is CpG No. 21 in the LEP promoter,
whose senescence-related methylation may impair upregulation of the gene upon adipogenic
stimulation.
Conclusion: Senescent ASCs display reduced in vitro differentiation ability and transcriptional
activation of adipogenic genes upon differentiation induction. These restrictions, however, cannot
in general be attributed to specific changes in DNA methylation at adipogenic promoters. There
also seems to be a correlation between CpGs that are hypomethylated and important transcription
factor binding sites.
Background
Mesenchymal stem cells (MSCs) have been identified in
many human tissues and are thought to be responsible for
tissue homeostasis. Adipose tissue constitutes an abun-
dant source of MSCs [1,2]. We have shown that adipose
stem cells (ASCs) with a CD45-CD31-CD34+CD105+ phe-
notype can be isolated with ~99% purity from the stromal
vascular fraction of human liposuction material [3].
Human ASCs exhibit primarily mesodermal differentia-
tion capacity in vitro [1], and in vivo may contribute to
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[6] and vascular functions [7]. ASCs display an immu-
nophenotype similar to bone marrow MSCs and express
genes extending across the three germ layers, supporting a
differentiation potential toward non-mesodermal line-
ages [3,8,9].
Single cell-derived clonal cultures of human ASCs, how-
ever, show that differentiation capacity in vitro varies
between cell clones [3]. Analysis of DNA methylation at
promoters of lineage-specific genes showed that freshly
isolated, undifferentiated ASCs display mosaically under-
methylated adipogenic gene promoters (LEP, PPARG2,
FABP4, LPL); in contrast, myogenic (MYOG) and
endothelial (CD31, CD144) promoters are hypermethyl-
ated [10,11]. Methylation of a cytosine in a CpG dinucle-
otide is a heritable modification that favors genomic
integrity, ensures proper regulation of gene expression
and is essential for long-term gene silencing [12]. Methyl-
ation profiles are maintained in clonal ASC cultures up to
4 passages, or 20 population doublings from single cells,
and do not correlate with gene expression level in undif-
ferentiated or differentiated cells [10]. The unmethylated
state of adipogenic promoters, together with the hyper-
methylation of endothelial and myogenic promoters and
the maintenance of these methylation patterns after adi-
pogenic, osteogenic or endothelial differentiation
[10,11,13] suggest that ASCs are epigenetically committed
to adipogenic differentiation preferentially over other lin-
eages.
Human and murine MSCs cultured in vitro undergo rep-
licative senescence and exhibit reduced differentiation
potential upon prolonged culture [14-19]. Loss of func-
tionality of senescent MSCs is presumably due to accumu-
lation of oxidative damage on DNA and proteins [20,21]
and to telomerase dysfunction [22]. In vivo, reduced abil-
ity of MSCs to contribute to tissue repair in aged individ-
uals has been attributed to a loss of MSC function rather
than to diminished stem cell numbers [23].
Aging is accompanied by changes in DNA methylation in
tumor suppressor genes [24] and by stochastic methyla-
tion events throughout the genome [25]. Culture may also
induce random DNA methylation errors as a result of infi-
delity in maintenance DNA methylation [26,27]. In this
study, we investigate the extent to which senescent clonal
cultures of human ASCs exhibit reduced differentiation
potential in vitro and whether this may be attributed to
changes in promoter DNA methylation.
Results
Senescent ASCs display reduced adipogenic differentiation 
potential
To investigate the effect of senescence on differentiation
ability of ASCs, we derived clonal cultures of ASCs from
single freshly isolated cells [3]. The adipogenic differenti-
ation capacity of these clones in early passage cultures
(passage 4; P4) has been described previously [10]. Three
clones, designated B1, B2 and B3, were cultured to senes-
cence. Senescence was reached at passage P18 (i.e., after
48 population doublings) for clone B1, P16 (44 popula-
tion doublings) for clone B2 and P17 (46 population
doublings) for clone B3. Senescence was manifested by
cell cycle arrest, as judged by the absence of cell division
on the basis of cell counts upon at least two rounds of sub-
culture after these passage numbers were reached (data
not shown), and by typical enlarged cell morphology (Fig.
1A). Passage number achieved at senescence is referred to
as Ps hereafter.
To evaluate the differentiation capacity of early passage vs.
senescent cells, all clones were induced to differentiate
toward the adipogenic pathway for three weeks, starting
either at P7 or at Ps. All P7 clones differentiated efficiently,
on the basis of Oil Red-O staining (Fig. 1B). Differentia-
tion, however, was impaired in senescent cells (Fig. 1C,
Ps). Note that differentiation was elicited for each clone
with 20,000 cells/cm2 both at P7 and at Ps, so we could
not attribute differences in the extent of adipogenesis to
differences in cell density.
Quantitative analysis of expression of adipogenic genes in
undifferentiated P7 and Ps cells by real time reverse tran-
scription (RT) polymerase chain reaction (PCR) corrobo-
rated the reduced ability of senescent ASCs to commit to
adipogenesis. In undifferentiated P7 cells, expression of
peroxisome proliferator-activated receptor gamma 2
(PPARG2) occurred at low levels and was not significantly
altered in senescent cells in any of the clones (P > 0.05;
Fig. 2A). Expression of fatty acid-binding protein 4
(FABP4) [28] mRNA, also detected at low levels at P7, was
unaltered at Ps in clone B2 (P > 0.1), but was upregulated
3-fold in clones B1 and B3 (P < 0.01 for each clone, rela-
tive to undifferentiated cells; Fig. 2A). Transcripts for lipo-
protein lipase (LPL) were undetectable at P7 or Ps in
clones B2 and B3, consistent with previous observations
[10], but were expressed at a low level in both P7 and
senescent cells in clone B1 (Fig. 2A). Lastly, leptin (LEP)
mRNA was undetected in clone B1 but was upregulated 5-
to 6-fold at senescence in clones B2 and B3 (P < 0.01 rel-
ative to undifferentiated cells; Fig. 2A). It is noteworthy
however, that all transcripts detected in undifferentiated
P7 ASCs were expressed at very low levels, as illustrated by
elevated Ct values (> 35) despite high real time PCR effi-
ciency (data not shown).Page 2 of 11
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moted upregulation of all genes relative to undifferenti-
ated cells in all clones (P < 0.01 for any gene examined),
except for LEP which remained unchanged in clone B3 (P
> 0.1; Fig. 2B). Extent of gene upregulation varied between
clones, reflecting differences in the ability of each clone to
commit to adipogenesis even in late passage culture (P <
0.01 between clones, for each gene). This is similar to
what we previously observed with the same clones at pas-
sage 4 [10]. Note, however, that a significant part of this
variation was due to the low levels of transcripts detected
in undifferentiated cells, small variations in which can
result in large differences in relative upregulation upon
differentiation (small variations in PCR efficiency also
affect quantification of mRNA levels [29]). Although tran-
scriptional activation took place, LPL mRNA levels in
clones B2 and B3, and LEP mRNA level in clone B3 could
not be quantified as these genes were not expressed in
Adipogenic differentiation of human ASC clones in early and late passageFigure 1
Adipogenic differentiation of human ASC clones in early and late passage. (A) Morphology of an ASC clone (B2) at P7 and at 
senescence (Ps). Arrow points to the nucleus of a large and flattened single cell at Ps. These phenotypes are typical for early 
passage and senescent human ASCs cultured clonally or as polyclones. (B) Three ASC clones (B1, B2, B3) were induced to dif-
ferentiate toward the adipogenic pathway for three weeks, starting at P7 (B) or Ps (C). Ps corresponded to P18 (clone B1), P16 
(clone B2) and P17 (clone B3). Cells were stained with Oil Red-O to visualize lipid droplets and with hematoxylin to visualize 
nuclei. Bars, 100 μm.Page 3 of 11
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and LPL mRNA levels in ASCs after three weeks of adipo-
genic stimulation at P7 were higher than after induction
of differentiation at Ps (P < 0.05 for FABP4 and P < 0.005
for LPL; one-sample t-test), while those of PPARG2 and
LEP were not different (P > 0.05, one-sample t-test; Fig.
2C). Impaired lipid accumulation and transcriptional
activation of adipogenic genes during culture of ASCs to
senescence illustrate a reduced commitment to adipogen-
esis, despite stable or moderately upregulated transcript
levels in undifferentiated cells.
Adipogenic promoter DNA methylation profiles remain 
stable upon culture to senescence
To determine whether reduced transcriptional level of adi-
pogenic genes in senescent ASCs had an underlying epige-
netic basis, we assessed the DNA methylation status in the
LEP, PPARG2, FABP4 and LPL promoters by bisulfite
sequencing. Bisulfite conversion of DNA relies on the
deamination of unmethylated cytosines into uracils,
while methylated cytosines are protected from deamina-
tion. PCR converts uracils to thymidines and sequencing
of several PCR products cloned in bacteria enables a quan-
titative assessment of the position and number of methyl-
ated cytosines in the region examined [30]. Regions
analyzed by bisulfite sequencing in the LEP, PPARG2,
FABP4 and LPL promoters are shown in Fig. 3A. We first
validated the significance of the regions examined by
showing that the extent of methylation was consistently
lower in all promoters in differentiated SGBS (Simpson-
Golabi-Behmel Syndrome) human adipocytes (0–45%
methylated CpGs) than in peripheral blood T cells (24–
72% methylation; Fig. 3B; P < 10-4 for each promoter; t-
test).
DNA methylation profiles of undifferentiated senescent
cells are shown in Fig. 4A and illustrated for all individual
clones in Additional file 1, Supplementary Fig. 1. The LEP,
PPARG2 and LPL promoters were largely hypomethylated
in all clones examined, with percentages of methylation
ranging from 7 to 29% (Table 1, Undifferentiated). We
found that the preferred areas of methylation in each
locus we previously identified in early passage (P4) cells
[10] were maintained in Ps cells (Fig. 4A). Furthermore, as
in P4 cells, methylation profiles were mosaic in senescent
cells, both between ASC clones and within a clonal popu-
lation (Fig. 4A). The FABP4 promoter displayed greater
variation in global methylation with clone B2 being 25%
methylated, while B3 was 75% methylated (Fig. 4A; Table
1, Undifferentiated; Additional file 1, Supplementary Fig.
1C). Note that although adipogenic differentiation poten-
tial was evaluated in ASCs at P7 in this study, early passage
methylation status was previously determined at P4 [10];
however no or minimal methylation differences were
Expression of adipogenic genes upon differentiation of P7 and senescent ASCsFigure 2
Expression of adipogenic genes upon differentiation of P7 and 
senescent ASCs. (A) LEP, PPARG2, FABP4 and LPL transcript 
levels were determined in undifferentiated Ps cells (clones 
B1, B2, B3) relative to undifferentiated P7 cells. For each 
clone, the mRNA level detected at P7 was attributed a value 
of 1 and the mRNA level in the same clone at Ps was 
expressed relative to that. A value of 0 (no bar) indicates that 
the gene is not expressed. (B) At senescence, each clone was 
induced to differentiate and mRNA levels compared to those 
of undifferentiated cells (level 1). 'ND' indicates that the gene 
was upregulated but relative levels could not be determined 
because transcripts were undetected in undifferentiated cells 
(jagged bars). (C) Transcript levels in cells differentiated at P7 
were expressed relative to those in cells differentiated at Ps 
(level 1). Each panel shows the mean fold upregulation from 
triplicate RT-PCRs from at least two separate cDNA prepa-
rations.Page 4 of 11
(page number not for citation purposes)
BMC Cell Biology 2007, 8:18 http://www.biomedcentral.com/1471-2121/8/18anticipated between P4 and P7, relative to senescence
(P16-18).
Methylation profiles of each promoter in senescent cells
(Fig. 4B, red lines) were compared to those obtained ear-
lier [10] in the same ASC clones cultured to P4 (Fig. 4B,
green lines). Methylation profiles remained overall simi-
lar during culture to senescence (Fig. 4A, B). However, two
CpGs were found to be hypermethylated in FAPB4 (CpGs
1 and 2; P < 0.01 and P < 0.001, respectively; t-tests),
owing to hypermethylation in clones B1 and B3 (Addi-
tional file 1, Supplementary Fig. 1C). Moreover, we found
one CpG to be hypomethylated in LPL (CpG 6; P < 0.001;
t-test; Fig. 4B) also owing to demethylation of this cyto-
sine in clones B1 and B3 (Additional file 1, Supplemen-
tary Fig. 1D). When global percentages of methylation
were compared between undifferentiated individual ASC
clones at P4 and Ps, however, LEP, PPARG2 and FABP4
were found to be hypermethylated upon senescence in
clone B1, while clones B2 and B3 only showed LEP and
FAPB4 hypermethylation, respectively (Table 1, Undiffer-
entiated). LPL promoter methylation was reduced
between P4 and Ps in clone B1 and remained stable in the
other clones (Table 1, Undifferentiated).
These results indicate that overall, adipogenic promoters
retain the largely hypomethylated profile that character-
izes ASCs. Nevertheless, a few CpGs become hyper- or
hypomethylated upon senescence in the FABP4 and LPL
promoters, respectively, albeit not in all clones.
Adipogenic differentiation maintains methylation profiles 
at adipogenic promoters in senescent ASCs
We next examined the methylation profile of adipogenic
promoters after adipogenic stimulation in senescent cells
and compared these profiles to those of cells differenti-
ated at P4 [10]. Methylation patterns were similar in the
LEP promoter in differentiated P4 and Ps cells (Fig. 4C, D;
Table 1, Differentiated), with only two CpGs, No. 5 and 21,
being hypermethylated at Ps (P < 0.01; t-tests; Fig. 4D).
Upon examination of individual clones, however, clones
B2 and B3 displayed enhanced methylation at senescence
(P < 0.001; t-tests; Table 1, Differentiated) due to hyper-
methylation of several CpGs (Additional file 1, Supple-
DNA methylation analysis of adipogenic promoters in human adipocytes and T cellsFigure 3
DNA methylation analysis of adipogenic promoters in human adipocytes and T cells. (A) Map of CpG dinucleotides (tick 
marks) examined in the LEP, PPARG2, FABP4 and LPL promoters. Regions examined are indicated by the continuous line. Num-
bers are relative to the transcription start site (TSS). (B) Bisulfite sequencing of LEP, PPARG2, FABP4 and LPL promoters in dif-
ferentiated human SGBS adipocytes and in purified peripheral blood T cells. Ten bacterial clones of PCR products were 
sequenced. Each row represents one bacterial clone with one circle symbolizing one CpG. Top numbers indicate position of 
CpGs relative to the TSS. Bottom numbers are CpG numbers, with No. 1 being the 5'-most cytosine in the sequence exam-
ined.Page 5 of 11
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seen at Ps compared to P4 (Fig. 4C, D; Table 1, Differenti-
ated; P = 0.011; t-test) due to hypermethylation of CpGs
No. 4, 5 and 6 (Fig. 4D; P < 0.001 for each cytosine; t-tests;
Table 1; Additional file 1, Supplementary Fig. 2B). The
FABP4 and LPL promoters displayed remarkably similar
methylation profiles in Ps and P4 differentiated cells (Fig.
4C, D), with only clone B3 showing FABP4 hypermethyl-
ation in differentiated Ps cells (Table 1) due to enhanced
methylation of CpG 2 (Additional file 1, Supplementary
Fig. 2C). Finally, we found that methylation profiles of all
promoters were overall similar in undifferentiated and in
adipogenic-stimulated Ps cells (Fig. 5, showing a direct
comparison of data of Figs. 4B and 4D, red curves), except
for hypermethylation of CpG 5 in the LEP promoter (Fig.
5; P < 0.01; t-test). We concluded that overall, methylation
patterns in adipogenic promoters are similar between adi-
pogenic-stimulated cells in early passage and at senes-
cence. However, as with undifferentiated cells, specific
CpGs appear to be hyper- or hypomethylated in a pro-
moter-specific and cell clone-specific manner.
We occasionally noted the substitution of a cytosine for a
thymidine (C:T substitutions) in some LEP bisulfite
sequences, consistently at CpG No. 4 (Fig. 4A, C, blue
marks). Sequences were unambiguous and displayed
either a methylated C or an unmethylated C (the latter
read as A, as shown in Additional file 1, Supplementary
Fig. 3A) or, unexpectedly a T (read as a T; Additional file
1, Supplementary Fig. 3B). To account for this substitu-
tion, it has been proposed that CpG methylation increases
the mutation rate from CpG to TpG or CpA, as suggested
by the lower number of CpGs observed over that expected
in mammalian genomes [31,32].
In summary, methylation profiles at adipogenic promot-
ers are generally maintained upon clonal culture of ASCs
to senescence. Nevertheless, at the level of individual
clones, methylation may be differentially affected in a
gene-independent manner, but this does not necessarily
correlate with transcriptional changes. Adipogenic stimu-
lation of early passage or senescent cells does not mark-
edly affect adipogenic promoter DNA methylation.
Discussion
Reduced adipogenic differentiation potential of senescent 
ASCs is not related to changes in promoter DNA 
methylation
Little is known on alterations in DNA methylation in
MSCs during in vitro aging and how these may relate to
changes in differentiation potential. We examined three
clonal lines of ASCs with an ability to differentiate toward
adipogenic [10], osteogenic and endothelial pathways
[11,13]. Similarly to cultured bone marrow MSCs [20,33],
all ASC clones cultured to senescence displayed reduced
adipogenic differentiation potential in vitro, on the basis
of lipid synthesis and transcriptional upregulation of, pri-
marily, FABP4 and LPL relative to the same clones in early
passage cultures. Interestingly however, basal transcrip-
tion of these genes was unaltered (PPARG2, LPL) or mod-
erately enhanced (FABP4, LEP) in undifferentiated cells at
Ps. Thus, reduced transcription efficiency in differentiated
senescent cells cannot be attributed to lower transcript
levels in the undifferentiated state.
What may be the basis for reduced adipogenic potential in
senescent ASCs? First, PPARG2, a master regulator of adi-
pogenesis [34], is upregulated to a level similar in early
passage and senescent cells, thus we cannot explain
Table 1: Percentage of CpG methylation in the LEP, PPARG2, FABP4 and LPL promoters in undifferentiated and differentiated ASC 
clones at passage 4 (P4) and at senescence (Ps)
Percent methylated cytosines in promoter region examined
Gene LEP PPARG2 FABP4 LPL
Passage No. P4 Ps P4 Ps P4 Ps P4 Ps
Undifferentiated
ASC clone B1 9 17a 10 20c 15 45a 20 8a
B2 7 14a 15 18ns 30 25ns 27 26ns
B3 24 24ns 29 23ns 50 75a 19 19ns
Differentiated
ASC clone B1 13 13ns 5 33a 12 13ns 17 11ns
B2 4 17a 17 25c 22 25ns 29 24ns
B3 22 38a 17 22ns 50 70b 18 14ns
Chi-square tests: a P < 0.001; b P < 0.005; c P < 0.05; ns non-significant.Page 6 of 11
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adipogenic stimulation of senescent cells upregulates LPL
expression, albeit to a lower level than in early passage
cells. A suboptimal transcription level is likely to affect
translation, preventing further phenotypic changes. Of
note, transcription without detectable protein expression
seems to be a feature of undifferentiated ASCs [3]. Third,
transcription or synthesis of transcriptional regulators of
adipogenic genes, such as C/EBPα [34], BMP4 [35] or
ADD1/SREBP1c [36] may be compromised in senescent
cells and may account for adipogenesis deficiency despite
the putative availability of binding sites (see below).
Indeed, failure to express C/EPBα results in inability to
develop white adipose tissue in vivo [37,38]. Fourth, adi-
pogenic failure may also be due to impaired downregula-
tion of GATA2/3, pre-adipocyte factor 1 or Wnt10b,
whose expression blocks cells in a pre-adipocyte stage
[39].
To determine whether there was an epigenetic basis for
reduced differentiation potential in senescent cells, we
examined the DNA methylation profiles in the LEP,
DNA methylation analysis of adipogenic promoters in undifferentiated and differentiated ASCs at passage 4 (P4) and senes-cence (Ps)Figure 4
DNA methylation analysis of adipogenic promoters in undifferentiated and differentiated ASCs at passage 4 (P4) and senes-
cence (Ps). (A) Bisulfite sequencing of LEP, PPARG2, FABP4 and LPL in undifferentiated Ps cells. Numbers are as in Figure 3. (B) 
Percentage of individual methylated CpGs (●  in A) in undifferentiated P4 (green) and Ps (red) cells (average of clones B1, B2, 
B3). Data for individual undifferentiated ASC clones are shown in Additional file 1, Supplementary Figure. (C) Bisulfite sequenc-
ing of Ps cells after adipogenic differentiation. Numbers are as in Figure 3. (D) Percentage of individual methylated CpGs (●  in 
C) in differentiated cells at Ps. Data for individual differentiated clones are shown in Additional file 1, Supplementary Figure 2. 
**P < 0.01, ***P < 0.001 (t-tests).Page 7 of 11
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tained the overall mosaic hypomethylation of LEP,
PPARG2 and LPL previously reported in P4 cells [10].
FABP4 exhibited hypermethylation in two undifferenti-
ated ASC clones (B1, B3) at senescence. However, this did
not correlate with reduced transcription potential upon
adipogenic stimulation because clone B2, which is not
hypermethylated at senescence, showed similar a reduc-
tion in transcription level to clones B1 and B3. Mosaic
methylation has been reported in other primary cell cul-
tures [26,27,40] and is likely the result of stochastic errors
in maintenance methylation which occur over many
rounds of replication. On the basis of our observations,
therefore, it is difficult to attribute any change in promoter
methylation to an effect of senescence per se.
Relationship between CpG methylation and binding of 
transcriptional regulators
Identification of relationships between the most
hypomethylated areas in adipogenic promoters and bind-
ing sites for transcription factors argues that most, but not
all, these sites remain available during culture. In the LEP
promoter, methylation of CpGs No. 4–6 in clones B2 and
B3 covers a recognition site for the methyl-CpG binding
protein Kaiso [41,42]. Moreover, two Sp1binding sites
span CpGs No. 15 and 16 while CpG No. 17 lies in a site
occupied by an unidentified factor [43]. CpGs No. 15–17
are unmethylated at P4 and at senescence, presumably
leaving these binding sites available. Additionally, CpG
No. 21 lies within a C/EBPα recognition site flanked by E
boxes for putative ADD1/SREBP1 binding, all of which
are important for LEP expression [43,44]. In contrast to
CpGs No.15–17, CpG No. 21 is hypermethylated in
senescent ASCs, but only in the context of adipogenic
stimulation, in clones B1 and B3. CpG No. 21 hypermeth-
ylation may account for limited or undetectable LEP
upregulation in adipogenic stimulated senescent cells.
Moreover, we found that LEP transcripts increased 5–6-
fold in undifferentiated senescent clones B2 and B3, but
not in clone B1, which displayed heaviest methylation on
CpG No.21. Therefore, methylation of CpG No.21 corre-
lates with impaired LEP transcriptional upregulation in
senescent cells in the context of adipogenic stimulation.
Methylation profiles of the LPL and FABP4 promoters fur-
ther illustrates a functional relationship between DNA
methylation and transcription factor binding. The LPL
promoter contains a PPAR responsive element between
CpGs No. 7 and 8 [45,46], a sterol-responsive element act-
ing as binding site for SREBP1c [36], and between CpGs
No. 9 and 10, a CAAT box and a binding sequence for
Oct1 and TFIIB. Notably, CpGs No. 7–11 are consistently
unmethylated in both early and late passage ASCs,
thereby enabling transcriptional activation of LPL upon
differentiation even in senescent cells. Availability of tran-
scription factor binding sites in senescent ASCs also yields
for the FABP4 promoter, which is strongly activated upon
adipogenic stimulation. Notably, this promoter harbors a
C/EBPα binding site close to CpG No. 4 [47], the only
cytosine unmethylated regardless of ASC donor [10], cell
clone and differentiation state in early passage and in
senescent cells.
Promoter DNA methylation during senescence and aging
Stochastic methylation in senescing ASCs is reminiscent
of random methylation patterns established in human
intestinal crypt stem cells in aging individuals [48,49].
Aging-related random methylation has been proposed to
occur as a result of failure of maintenance methyltrans-
ferase activity, and/or exposure to environmental factors
and health of the individual [24,50,51]. Our results pro-
vide evidence that methylation changes detected in senes-
cent ASCs do not correlate with transcriptional defects
and reduced differentiation potential. Likewise, there is to
date little evidence linking DNA methylation of lineage-
specific genes and aging-related impairment of stem cell
function (tissue homeostasis) [20], stochastic changes in
gene expression [52] and genome integrity [53]. Neverthe-
less, comparing aging to in vitro replicative senescence
should be made with caution, as age of MSCs does not
always affect differentiation potential in vitro [54].
In summary, our results argue that reduction of adipo-
genic potential in senescent ASCs may relate to transcrip-
tional defects upon adipogenic stimulation. However, it
cannot in general be attributed to specific methylation
DNA methylation profiles of adipogenic promoters in undif-ferentiated and i  adipogenic stimulated senescent ASCsFigure 5
DNA methylation profiles of adipogenic promoters in undif-
ferentiated and in adipogenic stimulated senescent ASCs. 
Data were obtained by bisulfite sequencing as shown in Fig-
ure 4. Percentages of methylated CpGs are shown (average 
of clones B1, B2 and B3). **P < 0.01 (t-test).Page 8 of 11
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bility of transcription factor binding sites regulated by
CpG methylation. One exception to this contention is one
CpG in the LEP promoter (CpG No. 21 in the present
study), whose senescence-related methylation may impair
upregulation of the gene upon adipogenic stimulation.
There also seems to be a correlation between regions of
CpGs hypomethylation and important transcription fac-
tor binding sites.
Conclusion
ASCs cultured to senescence display reduced in vitro dif-
ferentiation ability and transcriptional activation of adi-
pogenic genes. These restrictions, however, cannot be
attributed to specific changes in DNA methylation on adi-
pogenic promoters. There also seems to be a correlation
between CpGs that are hypomethylated and important
transcription factor binding sites.
Methods
Adipose stem cell isolation and clonal culture
Cells with a CD45-CD31-CD34+CD105+ phenotype
(ASCs) were isolated from the stromal vascular fraction of
human adipose tissue as described [3]. In short, lipoaspi-
rates obtained from the hip or thigh regions of female
donors below 40 years of age were digested with colla-
genase and DNase I, and adipocytes were separated from
stromal vascular cells by centrifugation. Stromal cells were
strained through sieves and CD45- cells were retrieved by
negative selection. CD31- cells were in turn negatively
selected using FITC-conjugated anti-human CD31 anti-
bodies and anti-FITC microbeads. Isolated ASCs are
CD34+CD105+so no negative selection was performed for
these markers [3]. For clonal expansion, single freshly iso-
lated ASCs were cultured in 48-well plates in DMEM/F12
medium containing 50% fetal bovine serum. After ~16 h,
the medium was replaced with DMEM/F12/10% fetal
bovine serum and after 3 weeks, colonies were passaged
by trypsinization. The three ASC clones used in this study
(clones B1, B2, B3) have been previously characterized for
their ability to differentiate toward adipogenic, osteogenic
and endothelial cell lineages [10,11,13].
Adipogenic differentiation
Cells were cultured to confluency in DMEM/F12/10%
serum and stimulated for 3 weeks with 0.5 mM 1-methyl-
3 isobutylxanthine, 1 μM dexamethasone, 10 μg/ml insu-
lin (Novo Nordisk) and 200 μM indomethacin (Dumex-
Alpharma). To visualize lipid droplets fixed cells were
stained with Oil Red-O as described earlier [3].
Quantitative RT-PCR
Total RNA was purified using the DNAse-containing RNe-
asy Micro Kit (Qiagen). RT-PCR was carried out from 500
ng total RNA using the Iscript cDNA synthesis kit (Bio-
Rad). Quantitative RT-PCR reactions were performed in
triplicates from two separate cDNA preparations on a
MyiQ Real-time PCR Detection System using IQ SYBR®
Green (BioRad). RT-PCR primers used have been pub-
lished earlier [10]. SYBR® Green PCR conditions were
95°C for 4.5 min and 40 cycles of 95°C 30 sec, 60°C 30
sec and 72°C 30 sec, and transcript levels calculated [29]
using GAPDH as a normalization control [10]. RT-blank
control PCRs showed no product amplification for all
genes examined in this study (data not shown). Relative
transcripts levels were compared using paired t-tests and
statistical significance expressed as a two-tailed P value
with P < 0.05 considered as significant. When relevant,
transcript levels were compared to a "reference" level
(level 1) using one-sample t-tests.
Bisulfite sequencing
Methylation of four adipogenic gene promoters was ana-
lyzed by bisulfite sequencing. The LEP promoter region
examined, and known to be regulated by methylation
[44], covered nucleotides 2719–2937 (GenBank U43589)
and spanned 27 potentially methylated cytosines within
nucleotides -203 to +16 with respect to the transcription
start site (TSS). The PPARG2 promoter region [55]
spanned nucleotides 108–587 (GenBank AB005520) and
included 6 CpGs within nucleotides -620 to – 140 with
respect to the TSS. The FABP4 (GenBank NM_001442)
promoter region encompassed 4 CpGs within nucleotides
-478 to -65 with respect to the TSS. The LPL promoter
region (GenBank X68111) spanned bases 1321–1777 and
included 11 CpGs within nucleotides -398 to +59 with
respect to the TSS. Sequence positioning was identified
using Ensembl [56].
For bisulfite conversion, DNA was purified by phenol-
chloroform-isoamylalcohol extraction. Cells were lysed
for 10 min in lysis buffer (10 mM Tris-HCl, pH 8, 100 mM
EDTA, 0.5% SDS) and digested with 0.1 mg/ml Proteinase
K overnight. Bisulfite conversion was performed using the
MethylEasy DNA Bisulfite Modification kit as detailed by
the manufacturer (Human Genetic Signatures) [10]. Con-
version rates, assessed by conversion of all cytosines in
non-CpG dinucleotides to uracils (reading as thymidines
after PCR), was 100% (data not shown). Converted DNA
was used fresh or stored at -20°C. Converted DNA was
amplified by PCR using primers commercially available
(Human Genetic Signatures) for LEP. Primers for
PPARG2, FABP4 and LPL were designed using Methprimer
[57] and previously reported [10]. For PPARG2, FABP4
and LPL, PCR conditions were 95°C for 7 min and 40
cycles of 95°C 1 min, 54°C 2 min and 72°C 2 min, fol-
lowed by 10 min at 72°C. For LEP, nested PCRs were per-
formed, each with 95°C for 3 min and 30 cycles of 95°C
1 min, 50°C 2 min and 72°C 2 min, followed by 10 min
at 72°C. PCR products were cloned into E. coli by TOPOPage 9 of 11
(page number not for citation purposes)
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Biotech).
Methylation data are represented as filled circles (methyl-
ated CpG) and empty circles (unmethylated CpG) for
each bacterial clone obtained. Each row of circles repre-
sents methylation pattern based on the sequence of one
cloned PCR product (i.e., one genomic allele). Global
methylation percentages for a given promoter were com-
pared using paired t-tests. Numbers of methylated
cytosines for a given CpG were compared between cell
populations using paired t-tests and significance was
expressed using two-tailed P values.
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